Wird geladen...
Initial Testing of VNP40101M (Cloretazine(®)) by the Pediatric Preclinical Testing Program
VNP40101M is a novel alkylating agent that yields two reactive compounds (a chloroethylating species and methylisocyanate) and has demonstrated activity against a wide spectrum of tumor xenografts. VNP40101M was tested against an in vivo panel of 5 pediatric brain tumor xenografts at a dose of 18 mg...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2008
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2836208/ https://ncbi.nlm.nih.gov/pubmed/18493996 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.21620 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|